Life sciences company awarded Small Business Innovation Research (SBIR) Grant from National Cancer Institute Branford, Conn. IsoPlexis Corporation (IsoPlexis), a venture-capital funded life sciences company developing an innovative cellular response analysis platform to measure the proteomic function of individual cells in patients, today announced it was recently awarded a competitive Phase I Small Business Innovation […]
Eden Prairie, Minn. – MTS Systems Corporation (NASDAQ: MTSC) (the “Company”), a leading global supplier of high-performance test systems and sensors, today announced that the lenders under its current credit agreement have waived any default that would have resulted from failure to provide the Company’s audited financial statements for the fiscal year ended October 1, 2016 (“Fiscal […]
ROCHESTER, NY and ST LOUIS, MO – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development and commercialization […]
MENLO PARK, Calif. — Synthomics, Inc., an emerging developer of next-generation systems for oligonucleotide synthesis, announced today that it has completed seed round financing and has launched an early access program for its end-to-end DNA synthesis platform. The financing round was anchored by TEEC Angel Fund (https://www.teec-angel.com), a Palo Alto, CA-based Micro VC fund with an […]
Ghent, Belgium PharmaFluidics NV, a game-changing innovator in the field of analytical chromatography, announced today that it has raised 2.7 million euro of additional funding. The funding was subscribed by a consortium of PharmaFluidics’ existing shareholders, new investors and management. Shareholders include Qbic Arkiv Fund, the Flemish investment company PMV, Theodorus Fund, Innovation Fund and […]
Adjustment to capital structure through reduction in number of shares outstanding and direct capital repayment set for completion in January 2017 Venlo, the Netherlands – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) (the “Company”) today announced details for completion of a synthetic share repurchase plan that combines a direct capital repayment with a reverse stock […]
Luxendo intends to use funds to drive the uptake of its Single Plane Illumination Microscopes internationally Heidelberg, Germany — Luxendo, a privately held start-up spun out of the European Molecular Biology Laboratory and developing its proprietary Single Plane Illumination Microscopy (SPIM) technology for biomedical research, announces today that the total capital raised in the Series […]
Sales Growth Soars to over 80% for 2016 NEWS – Bournemouth, UK: Solentim, the leader in Cell Line Development instrumentation, announce another record year of sales. “We have seen worldwide order values increase by over 80% year-on-year for calendar year 2016, and now nine out of the Top Ten Pharma have purchased Cell Metric for their […]
– Expected Full Year 2016 Revenue Growth of 36% to 39% Year over Year – SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the year ended December 31, 2016. Financial Highlights: Total revenue for 2016 expected to be in […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced preliminary revenue for the fourth quarter and full year ended December 31, 2016. Total revenue for the fourth quarter of 2016 is expected to be in the range of approximately $24.7 million to $25.2 million based on preliminary, unaudited financial data. At the midpoint of the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
